Enliven Therapeutics, Inc. logo ELVN - Enliven Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 7
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $69.50 DETAILS
HIGH: $80.00
LOW: $59.00
MEDIAN: $69.50
CONSENSUS: $69.50
UPSIDE: 67.31%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 28.66
Quick Ratio 28.66
Solvency Ratio -6.202
Cash Ratio 5.97

Valuation Ratios

Ratio Value
Price/Earnings
-8.42
Peers avg: 9.5
PEG Ratio 2.65
Forward PEG 2.65
Price/Book 1.90
Price/Sales 0.00
Price/FCF -12.38
Price/Op Cash Flow -12.41

Debt Ratios

Ratio Value
Debt/Assets 0.0008
Debt/Equity 0.0009
Debt/Capital 0.0009
Long-Term Debt/Capital 0.0000
Financial Leverage 1.04

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.243
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage -299.24
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -176.19
Operating Cash Flow Coverage -176.19
Capital Expenditure Coverage -444.94
Dividend + Capital Expenditure Coverage -444.94

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.830
Debt/Share 0.0070
Cash/Share 8.16
Book Value/Share 8.11
Tangible BV/Share 8.11
Equity/Share 8.11
Operating Cash Flow/Share -1.241
Capital Expenditure/Share 0.003
FCF/Share -1.243

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.867
Price/Fair Value 1.90
Debt/Market Cap 0.0005
Effective Tax Rate 0.0%
Enterprise Value Multiple -6.48